COMP <GO>
BLDR vs QXO // REVENUE GROWTH (YOY)
Builders FirstSource Inc. (NYSE) VS. QXO Inc. (NYSE) • 15-METRIC TALLY: BLDR 10
— QXO 2
▲ REVENUE GROWTH (YOY) LEADER: QXO
LAST: $64.91 (+2.93%) • MKT CAP: $6.79B
revenue-growth
-7.40%
LAST: $11.04 (-2.99%) • MKT CAP: $11.81B
revenue-growth
180.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLDR VS. QXO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLDR | QXO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.40% | 23.00% | +7.40 | BLDR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | -1.90% | +10.70 | BLDR | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.7x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.58% | -0.39% | +12.97 | BLDR | /fcf-yield <GO> |
| Operating Margin | 5.20% | -3.60% | +8.80 | BLDR | /operating-margins <GO> |
| Net Profit Margin | 2.90% | -4.10% | +7.00 | BLDR | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -7.40% | 180.00% | -187.40 | QXO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.34 | 1.79 | +0.55 | BLDR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | BLDR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 51.5 | +10.70 | BLDR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.92 | +0.20 | BLDR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 14.5x | 31.0x | -16.50 | BLDR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.79B | $11.81B | -$5.02B | QXO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLDR REV | QXO REV | BLDR GROSS % | QXO GROSS % | BLDR FCF | QXO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.19B | $6.84B | 30.4% | 23.0% | $853.3M | -$46.5M |
| FY 2024 | $16.40B | $56.9M | 32.8% | 40.6% | $1.49B | $84.7M |
| FY 2023 | $17.10B | $54.5M | — | — | $1.54B | -$1.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLDR // BETA 1.12
QXO // BETA 0.92